Teachers Advisors’s Clearside Biomedical CLSD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$80K Hold
3,874
﹤0.01% 2952
2018
Q4
$62K Buy
3,874
+576
+17% +$27K ﹤0.01% 2978
2018
Q3
$304K Sell
3,298
-31
-0.9% -$3.69K ﹤0.01% 2821
2018
Q2
$534K Buy
3,329
+651
+24% +$110K ﹤0.01% 2625
2018
Q1
$431K Hold
2,678
﹤0.01% 2594
2017
Q4
$281K Buy
2,678
+229
+9% +$24.6K ﹤0.01% 2827
2017
Q3
$321K Hold
2,449
﹤0.01% 2792
2017
Q2
$335K Buy
2,449
+1,367
+126% +$164K ﹤0.01% 2799
2017
Q1
$129K Buy
1,082
+221
+26% +$26.1K ﹤0.01% 2944
2016
Q4
$115K Buy
861
+279
+48% +$70K ﹤0.01% 2995
2016
Q3
$152K Buy
+582
New +$71.3K ﹤0.01% 2946

Other funds holding CLSD

Teachers Advisors's CLSD Position: Q1 2019 in Review

Teachers Advisors held its Clearside Biomedical (CLSD) position steady in Q1 2019 at 3,874 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #2952.

Teachers Advisors first reported a position in CLSD in Q3 2016 and has held it in 11 quarters since. The position peaked at $534K in Q2 2018. 57 funds tracked by Wall St. Rank hold CLSD as of Q1 2019.

  • Teachers Advisors held 3,874 shares of Clearside Biomedical worth $80K as of Q1 2019.
  • Teachers Advisors left its Clearside Biomedical share count unchanged in Q1 2019.
  • Clearside Biomedical made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2952 holding.
  • Teachers Advisors first reported a position in Clearside Biomedical in Q3 2016 and has held it in 11 quarters since.
  • Teachers Advisors's Clearside Biomedical position peaked at $534K in Q2 2018.
  • 57 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.